Covaris unveiled the M220™AFA™ (Adaptive Focused Acoustics) Ultrasonicator, which was designed specifically for use with low-cost benchtop next-generation GS sequencers. M220 reproducibly fragments DNA from 150 bp–3 kb, has integrated chilling to save space and cost, and uses standard AFA consumables, explained Brian Paras, director of international sales and strategic marketing.
The company also displayed its new g-TUBE™, a novel consumable for shearing 6 kb to 20 kb DNA fragments. “The g-TUBE has a simple load, spin, and collect design for use on a standard laboratory centrifuge,” continued Paras. “g-TUBE DNA shearing is fast, efficient, economical, and highly reproducible.”
Hamilton Storage Technologies introduced BiOS, the company’s third-generation automated system designed for ultra-low temperature storage of sensitive biological samples. According to Matt Hamilton, vp for Hamilton Storage Technologies, the scalable system ensures the integrity of 250,000 to more than 10 million sample tubes at temperatures down to -85°C.
All samples are stored in chest freezer compartments to maintain temperature stability. All internal workflows, including sample picking, are optimized to keep samples at ultra-low temperatures at all times, he continued, noting that system parts are easily accessible for service and maintenance.
“One- and two-dimension barcode reading and sample tracking produce complete chain-of-custody documentation, with software tools to support 21 CFR Part 11 compliance,” he said. “Multiple redundant back-up systems ensure the samples stay at -85°C, even in emergencies. The BiOS can store and process multiple labware types in the same system.”
Integra Biosciences launched its Viafill™ bulk reagent dispensing, multichannel pipetting and microplate washing instrument. The product comes with a choice of different tubing sets that allow the user to change between these three operation modes. Applications include reagent or media dispensing, cell seeding, plate washing, or serial dilutions.
Operating as a bulk reagent dispenser, the Viavill uses a choice of dispensing tube sets to enable reagent addition in volumes ranging from 0.5 µL to 10 mL into 6-, 12-, 24-, 48-, 96-, 384- and 1,536-well plates. A 16-channel tubing set is available to enable the filling of 384- and 1,536-well plates. All dispensing tubing sets are sold presterilized and are autoclavable enabling them to be re-used for further experiments, noted a company spokesperson.
Labcyte released a new software algorithm that, the company says, permits a greater range of fluid types to be automatically transferred with acoustic energy. “Dynamic Fluid Analysis™ enables the Echo® liquid-handling systems to adapt to fluid properties changes such as surface tension and viscosity and adjusts sound energy in real time with no operator intervention required,” pointed out Mark Fischer-Colbrie, CEO.
Several examples of the QPix 400 next generation of microbial colony pickers from Molecular Devices were on display at SLAS. The 400 series, which includes the QPix 450 and QPix 460, with a third system, the QPix 400, to follow later in 2012, features the option to simultaneously detect colonies and quantify fluorescent markers.
“This prescreening step enables the colonies of interest to be objectively identified and selected,” said Mark Truesdale, Ph.D., head of marketing. “Together with highly accurate robotics and organism-specific colony-picking pins, scientists can ensure that the right colony is picked every time, thus eliminating unnecessary work and expense downstream. An agar height sensor further increases accuracy at the picking stage.”
Applications include areas such as protein expression, biofuel research, enzyme evolution, phage display, DNA sequencing and library generation and management, added Dr. Truesdale.
Epigenetics took center stage, or rather center booth, at the PerkinElmer stand with the launch of high-throughput cellular assays that reportedly allow for the direct measurement of endogenous epigenetic mark modulation for more relevant results.
These assays, based on the company’s ALPHA technology and LANCE® Ultra technologies, are “extremely simple and automatable,” to enable drug target validation and lead compound characterization, replacing more labor-intensive technologies such as Western blot and ELISA, according to Kevin Hrusovsky, president, life sciences and technology at PerkinElmer.
“In addition, the expanded epigenetic biochemical enzymatic assays and detection reagents are specifically validated for drug discovery research, for disease states including oncology and neurodegenerative disorders,” he said.
The new products for SLAS included AlphaLISA cellular detection kits for H3K9 and H3K27, and AlphaLISA and LANCE Ultra In Vitro Toolbox that now covers over 30 validated enzymatic assays for readers and writers of the histone code, continued Hrusovsky.